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SUMMARY
The prevalence of allergic disorders, especially allergic rhinitis (AR), has dra-
matically increased in the past few decades and multicentre, standardized, 
randomized epidemiological studies are required to quantify this phenomenon 
in Poland. 
Aim: The aim of the study was to estimate the prevalence of rhinitis and 
allergic rhinitis in Poland.
Material and Method: The ECAP study was conducted using the ECRHS II 
and ISAAC questionnaires translated into the Polish language and validated, in 
selected nine regions of Poland, including eight cities and one rural area. The re-
spondents within the regions were selected by means of multistage proportional 
stratiﬁ ed random sampling based on the identity number (PESEL) as the operat. 
The survey was conducted in 20 454 subjects (response rate of 41.9%) and 18 
617 questionnaires were valid. Approximately 25% of the subjects (n=4783) 
were subsequently evaluated by clinicians (response rate of 43.4%).
Results: Rhinitis was self-reported by 36.08% of the respondents (37.8% of 
6-7 year olds, 34.5% of 13-14 year olds, and 36.0% of adults). The lowest 
prevalence rate was in the rural region (22.9%). Allergic rhinitis (AR) was 
self-reported by 22.54% of the respondents (23.6% of 6-7 year olds, 24.6% 
of 13-14 year olds, and 21.0% of adults). Again, the lowest prevalence rate 
was in the rural region (16.0%). AR was more frequent in males (24.0%) 
than in females (21.2%) (OR= 1.079; 95%CI: 1.044-1.116). AR was actually 
diagnosed by a clinician in 28.9% , including intermittent AR in 47.7% and 
persistent AR in 52.3%. Seasonal AR was diagnosed in 15.55%, and peren-
nial rhinitis in 15.2% 
Conclusion: Allergic rhinitis is common in Poland as it affects nearly 25% of 
the population and it is a major social problem. Standards of early detection 
and prevention of allergic rhinitis should be introduced.
Hasła indeksowe: epidemiologia, nieżyt nosa, alergiczny nieżyt nosa, ECAP, 
ECRHS II, ISAAC
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Introduction
Rhinitis is defined by the European Academy of Allergol-
ogy and Clinical Immunology (EAACI) as inflammation 
of the nasal mucous membrane manifested by one or 
more typical clinical symptoms: watery rhinorrhoea, 
itching, sneezing, and nasal congestion and obstruction. 
According to its specific pathomechanism, rhinitis is 
classified into allergic rhinitis (AR), eosinophilic non-al-
lergic rhinitis and infectious rhinitis. The updated ARIA 
(Allergic Rhinitis and its Impact on Asthma) report of 
2008 proposes a new classification of AR based on the 
duration of clinical symptoms, into intermittent and 
persistent rhinitis with an additional division based 
on the severity of symptoms, i.e. mild and moderate-
severe. The traditional classification of AR into seasonal 
and perennial may be still found in the literature. The 
symptoms of seasonal rhinitis are observed during the 
pollen season when the concentrations of allergens in 
the air are high. However, since the periods of pollina-
tion vary a lot depending on the geographical region, 
this classification is less universal [1, 2, 3].
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These different definitions of rhinitis make com-
parison of epidemiological data difficult. Such reports 
however are very important and international medical 
organizations conduct numerous studies to assess the 
epidemiology of allergic disorders. The International 
Study of Asthma and Allergy in Childhood (ISAAC) 
conducted in the years 1992-2003 in children aged 6-7 
years and 13-14 years and The European Community 
Respiratory Health Survey (ECRHS) conducted twice 
in the 1990s in adults aged 20-44 years are among 
the most comprehensive and highest regarded surveys. 
They have increased our knowledge of the causes of 
asthma, atopic rhinitis and eczema. What is very impor-
tant they have allowed definition of standards required 
of epidemiological studies to evaluate the prevalence of 
allergic disorders and assess how advanced they are. 
Introduction of questionnaires including very simple 
questions allowed standardizing of diagnostic criteria 
to be used internationally [4, 5, 6].
Both studies have confirmed that nowadays rhini-
tis is one of the most common respiratory disorders, 
especially allergic rhinitis, which affects mostly people 
of productive age. Although, AR is not a life-threaten-
ing condition and is not associated with high mortal-
ity, it has a huge socioeconomic impact as it affects 
people at the ages normally associated with active 
employment or attending school. AR symptoms such 
as rhinorrhoea, swelling and sneezing significantly 
affect the patients’ daily activities, their ability to get a 
good night’s sleep, performance at work or school, and 
their psychological wellbeing. Additionally, chronic 
rhinitis is often associated with serious complications 
such as rhinosinusitis, nasal polyps, recurrent otitis 
media and adenoid hypertrophy with sleep apnoea and 
sleep disturbances. What is very important allergic 
rhinitis and bronchial asthma frequently co-exist 
and one hypothesis proposes that they are mani-
festations of the continuum of one disease and have 
the same underlying pathophysiological mechanism, 
with implications for the diagnosis and treatment of 
AR [7, 8, 9, 10].
The efficacy of prophylaxis and treatment largely 
depends on reliable epidemiological studies and on-
going evaluation of incidence and prevalence of the 
disease. Updated epidemiological information, i.e. data 
on incidence, prevalence and morbidity also allow 
evaluation of the extent of the disease in different age 
groups and geographical regions, estimation of the 
impact of such variables as race, gender and living 
conditions, and recognition of the risk factors – genetic 
and familial and environmental, both outside and 
inside the home [11]. 
An urgent need to complete and update epidemio-
logical data on allergic disorders, which would include 
information from a large part of the country was per-
ceived in Poland and a survey using validated and 
integrated questionnaires sourced from the ECRHS II 
and ISAAC met that need.
The aim of ECAP was to assess the prevalence of 
rhinitis and allergic rhinitis in a Polish population 
of children, adolescents and young adults using the 
methodology of ECRHS and ISSAC.
Material and methods
In total, 22 703 subjects participated in the survey, 
including 20 454 completing the main question-
naire and 18 617 questionnaires were ultimately 
accepted as satisfying the quality criteria. As in 
the ECRHS II and ISAAC, the survey was carried 
out in children aged 6/7 years and 13/14 years and 
young adults aged 20-44 years. The main part of 
the survey was conducted in 4 510 6/7 year olds 
(24.2% of the total), 4 721 13/14 year olds (25.4%) 
and 9 386 adults (50.4%). Table 1 shows subjects 
in particular subgroups by gender. In the clinical 
part of the study, 4 783 respondents (25.7%) were 
examined by a physician.
The study Epidemiology of Allergic Diseases in 
Poland (ECAP) is the continuation of the European 
Community Respiratory Health Survey II (ECRHS II) 
[5, 6] and its design also incorporates the principles 
and methodology of the International Study of Asthma 
and Allergy in Childhood (ISAAC) [4]. The ECAP sur-
vey was conducted in an adult population aged 20-44 
years (the ECRHS standard) and in children aged 6/7 
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Fig. 1. Mean prevalence (%) of rhinitis in Poland as assessed by ECRHS and 
ISAAC questionnaires (n=16817) 
RCRHS: VI76 15 Do you have any nasal allergies, including a runny nose caused 
by allergy to pollens (hay fever)?; V178 16 Have you ever had a problem with 
sneezing or a runny or blocked nose when you did not have a fever, a cold or 
the ﬂ u?
ISAAC: V432IM2 1 Have you ever had a problem with sneezing or a runny or 
blocked nose when you did not have a fever, a cold or the ﬂ u?; v437 IM2 6 
Have you ever had hay fever (runny nose caused by allergy)
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years and 13/14 years (the ISAAC standard) living in 
eight of the largest Polish cities and in one rural area. 
It consisted of two essential stages of field studies: a 
survey using the ECRHS and ISAAC questionnaires 
translated into the Polish language and validated and 
a medical examination performed according to the 
ECRHS II standard in 25% of the ECAP respondents. 
The study regions were selected according to ECRHS 
guidelines (Polish cities with more than 150 000 in-
habitants satisfied the criteria). Since people living in 
rural areas make up 39% of the Polish population, one 
rural area (the region of Zamość in the south-east of 
Poland) was included in the study. The study regions 
were deliberately chosen but the respondents within 
the regions were selected by means of multistage pro-
portional stratified random sampling based on the 
identity number (PESEL) as the operat. The survey 
was conducted using the method of Computer-Assisted 
Personal Interviewing (CAPI) with the Personal Digital 
Assistant (PDA) devices. All data were automatically 
transmitted to the study centre by means of the GPRS 
system. To maintain the standards of accuracy and 
reliability of the survey, four-stage on-going quality 
control of the collected data was performed.
The data were collected in the years 2006-2008. 
Adult subjects were surveyed using the original ECRHS 
II questionnaire, translated into the Polish language 
and validated while another questionnaire, based on 
the ISAAC questionnaire, was designed to survey chil-
dren. As it was necessary to compare findings in adults 
and in children, the two questionnaires were combined 
and used as one study instrument. The wording of 
questions concerning the occurrence of rhinitis and al-
lergic rhinitis is similar in both questionnaires, ECRHS 
and ISAAC, and the answers are largely very similar 
(Fig. 1). That is why in all age groups the prevalence of 
rhinitis and allergic rhinitis was estimated based on 
answers to the ECRHS questionnaire alone. Rhinitis 
was recognized based on the answers to the question 
Have you ever had a problem with sneezing or a runny 
Fig. 2. Percent of ‘Yes’ answers to the question about the 
presence of rhinitis manifestations by age group and region 
(n= 18 617). “Zamość” describes the rural area
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Fig. 4. Comparison of the prevalence rates for rhinitis (V178) and allergic rhini-
tis (V176) (n=18 617)
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or blocked nose when you did not have a fever, a cold 
or the flu? (subsequently referred to as rhinitis). The 
prevalence of allergic rhinitis was assessed based on 
the answers to the question Do you have any nasal 
allergies, including a runny nose caused by allergy 
to pollens (hay fever)? (subsequently referred to as 
allergic rhinitis – AR).
Assessment in a clinic included a physical exami-
nation, spirometry, assessment of nasal patency by 
PNIF and skin prick tests. Physicians who evaluated 
the study subjects made their diagnosis using the 
standardized criteria based on the ARIA classification. 
Intermittent AR was diagnosed when the symptoms 
persisted for <4 days/ week or <4 weeks/year and 
chronic AR was diagnosed when the symptoms per-
sisted >4 days/ week or >4 weeks/month. The ARIA 
classification is based on the criterion of duration 
and that is why the diagnoses of intermittent and 
chronic rhinits were mutually exclusive [1]. To zdanie 
jest niezbyt jasne – JC Seasonal and perennial AR was 
diagnosed based on its duration and the period when 
the symptoms occurred.
The study was approved by the Bioethics Commit-
tee at the Medical University of Warsaw and the Main 
Inspector for Personal Data Protection.
Results
The response rate, i.e. the percentage of people who 
agreed to participate in the survey, was 41.9%. Rhini-
tis proved to be the most common allergic disorder 
in the study population. The prevalence of rhini-
tis according to the answers to the question Have 
you ever had a problem with sneezing or a runny or 
blocked nose when you did not have a fever, a cold or 
the flu? differed in particular regions. The average 
reported prevalence of rhinitis was 37.8% (n=1705) 
in 6/7 year olds, 34.5% (n=1630) in 13/14 year olds 
and 36.0% (n=3383) in adults (the mean prevalence 
rate in the study population was 36.08%). The low-
est prevalence of rhinitis (22.9%, n=470) was found 
in the rural area and it was nearly twice as low as 
in the city of Gdańsk where it was over 44% (n=826). 
Detailed data on the number of ‘Yes” answers to the 
above question are presented in Fig. 2. The reported 
prevalence of AR symptoms was lower than that of 
rhinitis and on average was 23.6% (n=1065) in 6/7 
year olds, 24.6% (n=1160) in 13/14 year olds and 21.0% 
(n=1972) in adults (the mean prevalence rate in the 
study population was 22.54%). Similarly to rhinitis, 
allergic rhinitis was the least frequently reported in 
the rural area (16%, n=328) compared to the mean 
prevalence rate for cities (22.9%, n=3869). Detailed 
data are presented in Fig. 3. The prevalence of rhini-
tis and allergic rhinitis in particular regions by the 
subjects’ age is shown in Fig. 4.
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Fig. 5. Comparison of the prevalence rates for intermittent rhinitis (v622_002) 
and persistent rhinitis (v622_003) as diagnosed by allergologists (n=4783)
In total, 4783 people (1329 6/7 year olds, 1321 13/14 
year olds and 2133 adults) were seen in clinics. Allergic 
rhinitis was diagnosed in 1385 people, i.e. 28.9% of all 
assessed subjects, including intermittent AR in 660 sub-
jects (47.7%) and chronic AR in 725 subjects (52.3%). The 
distribution of intermittent and chronic AR in particular 
age group is presented in Fig. 5. Tests for seasonal and 
perennial AR were performed in 3597 subjects (table 2). 
Detailed data on seasonal and perennial allergic rhinitis 
diagnosed by study allergologists are presented in Figs 
6 and 7. Comparison of prevalence rates of rhinitis and 
allergic rhinitis self-reported in the questionnaires and 
actually diagnosed by allergologists is shown in Fig. 8.
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Discussion
The ECAP survey is the largest epidemiological study of 
allergic disorders in Central and Eastern Europe and 
the first to be validated. It is also one of the largest stud-
ies worldwide to be conducted in one country. In total, 
22 0703 people participated in the study and 18 617 
questionnaires were included in the final analysis. 
Since the ECAP used the same study instruments, 
i.e. standardized questionnaires and clinical evalua-
tion, as the ECRHS and ISAAC it has been possible to 
compare the epidemiology of allergic disorders in Poland 
and in industrialized countries. The results show the 
current state of Poles’ health and allow us to forecast 
how allergic disorders may develop in the very near 
future. Alas, the forecast is not optimistic.
In the ECAP study, allergic rhinitinis accounted for 
a very large proportion of all cases of rhinitis, which 
confirms the opinion that allergy is the most com-
mon cause of rhinitis [12]. In the Polish population 
surveyed, especially in the rural area, in the majority 
of cases, the cause of rhinitis was allergic, probably 
due to higher concentrations of airborne allergens. The 
ECAP results confirm reports by other authors who 
consider allergic rhinitis the predominating manifes-
tation of allergy. In the ECAP survey, in urban areas 
the prevalence rate of rhinitis was up to 45% while 
AR was reported by up to 28% of the respondents 
(mean prevalence rate of AR was 22.5%). In Europe, 
the mean prevalence of AR in adults estimated by 
ECRHS II was 20.9%. According to the ISAAC data 
in children and adolescents, it ranged from 1.4% 
in Albania to 39.7% in Portugal, mean 7.5% [4, 6]. 
Comparison with epidemiological data from other 
countries in different geographical regions, places 
Poland at the top of the list of the most hypersensitive 
societies. Rough estimates suggest a staggering figure 
of over 8.5 million patients suffering from allergic 
rhinitis. Assuming that two-thirds will need some 
kind treatment, either short- or long-term, this is a 
major socioeconomic problem and a real challenge for 
allergologists, ENT specialists, paediatricians and the 
entire health care system.
In most regions surveyed by the ECAP, allergic 
rhinitis was more frequent in children and adolescents 
than in adults. This trend is particularly worrying as it 
may reflect the growing incidence of upper respiratory 
allergy. Another concern is that AR is responsible for a 4 
to 8-fold increase in the risk for asthma and untreated 
it may result in asthma progression and frequent ex-
acerbations [7, 13, 14]. One possible conclusion from 
the ECAP is the need to persuade paediatricians and 
ENT specialists that early diagnosis and prevention of 
allergic rhinitis in children is mandatory.
The results of clinical evaluation confirm the sur-
vey findings and demonstrate a high prevalence of 
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allergic rhinitis in the Polish population. Differences 
in diagnosis, niejasne especially in adults, may be 
due to two factors. AR is frequently underdiagnosed 
in adults because patients do not consult a doctor and 
treat themselves with OTC products, and as a result 
their condition remains undiagnosed by a doctor. On 
the other hand, as frequently emphasized in reports 
of epidemiological studies, people who are ill are more 
willing to participate in the clinical evaluation part of 
a study, which may give a false picture of the actual 
morbidity.
Considering all that, it must be realized that aller-
gies, especially allergic rhinitis, are a serious medical, 
social and economic problem.
Conclusions
Rhinitis affects on average a third of the Polish popu-
lation while allergic rhinitis is found in 25%. Both 
are very common in children, adolescents and young 
adults and it is necessary to make paediatricians, 
ENT specialists and health care managers in Poland 
aware of this very important medical and socioeco-
nomic problem.
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